These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 28280336)

  • 1. Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer.
    Liang Y; Tian B; Zhang J; Li K; Wang L; Han J; Wu Z
    Int J Nanomedicine; 2017; 12():1699-1715. PubMed ID: 28280336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A NAG-Guided Nano-Delivery System for Redox- and pH-Triggered Intracellularly Sequential Drug Release in Cancer Cells.
    Liang Y; Zhang J; Tian B; Wu Z; Svirskis D; Han J
    Int J Nanomedicine; 2020; 15():841-855. PubMed ID: 32103941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin.
    Guo S; Zhang Y; Wu Z; Zhang L; He D; Li X; Wang Z
    Biomed Pharmacother; 2019 Oct; 118():109225. PubMed ID: 31325705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.
    Ni S; Qiu L; Zhang G; Zhou H; Han Y
    Int J Nanomedicine; 2017; 12():1565-1576. PubMed ID: 28280326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
    Wang Y; Zhang H; Hao J; Li B; Li M; Xiuwen W
    Drug Deliv; 2016 May; 23(4):1398-403. PubMed ID: 26079530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer.
    Rawal S; Bora V; Patel B; Patel M
    Drug Deliv Transl Res; 2021 Oct; 11(5):2030-2051. PubMed ID: 33215254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
    Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
    Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy.
    Sun J; Chen Y; Xu J; Song X; Wan Z; Du Y; Ma W; Li X; Zhang L; Li S
    Theranostics; 2020; 10(3):1136-1150. PubMed ID: 31938056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.
    Larson N; Yang J; Ray A; Cheney DL; Ghandehari H; Kopeček J
    Int J Pharm; 2013 Sep; 454(1):435-43. PubMed ID: 23827653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
    Emami J; Rezazadeh M; Sadeghi H; Khadivar K
    Pharm Dev Technol; 2017 May; 22(3):370-382. PubMed ID: 27689412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
    Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.
    Lu Z; Su J; Li Z; Zhan Y; Ye D
    Drug Dev Ind Pharm; 2017 Jan; 43(1):160-170. PubMed ID: 27553814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activity of combination therapy with PEGylated pemetrexed and gemcitabine for an effective cancer treatment.
    Vandana M; Sahoo SK
    Eur J Pharm Biopharm; 2015 Aug; 94():83-93. PubMed ID: 25968494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
    Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
    Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity.
    Jian Y; Zhao M; Cao J; Fan T; Bu W; Yang Y; Li W; Zhang W; Qiao Y; Wang J; Wen A
    Drug Des Devel Ther; 2020; 14():2355-2370. PubMed ID: 32606603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
    Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
    AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
    Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
    Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.